Suchergebnisse - "Gianotti, Nicola"

PubPharm (231)

81

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients

enthalten in: PloS one | 2017

von Gianotti, N. | Cozzi-Lepri, A. | Antinori, A. | +11

82

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

enthalten in: BMC infectious diseases | 2017

von Spagnuolo, V. | Galli, L. | Poli, A. | +8

83

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

enthalten in: BMC infectious diseases | 2017

von Spagnuolo, V. | Galli, L. | Poli, A. | +8

84

Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients

enthalten in: BMC infectious diseases | 2017

von Spagnuolo, V. | Galli, L. | Poli, A. | +8

85

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients

enthalten in: PloS one | 2017

von Gianotti, N. | Poli, A. | Galli, L. | +11

86

Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients

enthalten in: The Journal of infection | 2016

von Fabbiani, M. | Di Giambenedetto, S. | Poli, A. | +9

CommentOn: J Infect. 2014 Jan;68(1):77-84. - PMID 24055802

87

Monotherapy with darunavir/ritonavir or lopinavir/ritonavir versus standard antiretroviral therapy : a randomized clinical trial (2pm Study)

enthalten in: The new microbiologica | 2016

von Gianotti, N. | Galli, L. | Maserati, R. | +9

88

Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir

enthalten in: Medicine | 2016

von Gianotti, N. | Galli, L. | Poli, A. | +7

89

Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients

enthalten in: The new microbiologica | 2016

von Merli, M. | Galli, L. | Castagna, A. | +11

90

HIV Clinical Pathway : A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy

enthalten in: PloS one | 2016

von Croce, D. | Lazzarin, A. | Rizzardini, G. | +11